These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2154026)

  • 1. Chemosensitivity test for carcinoma of digestive organs.
    Maehara Y; Kohnoe S; Sugimachi K
    Semin Surg Oncol; 1990; 6(1):42-7. PubMed ID: 2154026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the subrenal capsule assay and succinate dehydrogenase inhibition test.
    Iwagaki H; Fuchimoto S; Orita K
    J Med; 1989; 20(3-4):251-60. PubMed ID: 2809423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental and clinical study in vitro chemosensitivity test for succinate dehydrogenase inhibition test].
    Maehara Y; Takeuchi H; Inutsuka S; Baba H; Kohnoe S; Sugimachi K
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):455-60. PubMed ID: 8452383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosensitivity differences between primary and metastatic lesions of clinical gastric cancer.
    Kusumoto H; Maehara Y; Kusumoto T; Anai H; Akazawa K; Sugimachi K
    Eur J Surg Oncol; 1988 Dec; 14(6):685-9. PubMed ID: 3192005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the subrenal capsule assay and succinate dehydrogenase inhibition test as drug sensitivity tests for cancer.
    Iwagaki H; Fuchimoto S; Orita K
    Acta Med Okayama; 1988 Jun; 42(3):121-7. PubMed ID: 3400481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity to six antitumor drugs differs between primary and metastatic liver cancers.
    Kanematsu T; Maehara Y; Kusumoto T; Sugimachi K
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1511-3. PubMed ID: 2846313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between succinate dehydrogenase inhibition test and subrenal capsule assay for chemosensitivity testing.
    Anai H; Maehara Y; Kusumoto H; Sugimachi K
    Oncology; 1987; 44(2):115-7. PubMed ID: 3574851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The sensitivity of 1,000 human tumors to antitumor drugs using the succinate dehydrogenase inhibition (SDI) test].
    Miyamoto K; Fukuchi K
    Rinsho Byori; 1990 Nov; 38(11):1273-8. PubMed ID: 2273570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro chemosensitivity test: succinate dehydrogenase inhibition (SDI) test].
    Maehara Y; Kohnoe S; Emi Y; Sakaguchi Y; Sugimachi K
    Rinsho Byori; 1990 Jan; 38(1):14-8. PubMed ID: 2308218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatocellular carcinoma sensitivity to antitumor drugs assayed using the succinate dehydrogenase inhibition test.
    Kanematsu T; Maehara Y; Matsumata T; Shirabe K; Akazawa K; Sugimachi K
    Oncology; 1991; 48(1):34-8. PubMed ID: 1846232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Targeted therapies in digestive oncology].
    Amram ML; Benamran DA; Roth AD
    Rev Med Suisse; 2011 May; 7(296):1131-2, 1134-6. PubMed ID: 21721202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs.
    Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Meyer C; Fukumoto M; Tobe T
    Anticancer Res; 1992; 12(4):1141-6. PubMed ID: 1386969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The succinate dehydrogenase inhibition test for evaluating biopsy specimens and resected tumors of advanced gastric cancer.
    Kimura H; Yonemura Y; Ohyama S; Tsugawa K; Kinoshita K; Ninomiya I; Kosaka T; Miwa K; Miyazaki I; Tanaka M
    Surg Today; 1992; 22(6):508-11. PubMed ID: 1472790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A biochemical evaluation of oral squamous cell carcinoma growth by measurement of specific activity of succinate dehydrogenase in the subrenal capsule assay.
    Munakata H; Kayada Y; Kawahara M; Sakamoto T; Yoshiga K; Takada K
    Int J Oral Maxillofac Surg; 1995 Jun; 24(3):216-20. PubMed ID: 7594755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Succinate dehydrogenase inhibition test for evaluating head and neck tumors.
    Nakashima T; Uemura T; Maehara Y; Sugimachi K
    Oncology; 1989; 46(3):162-8. PubMed ID: 2717126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiopathological and clinical value of laminin in digestive neoplasms].
    Renkes P; Felden F; Bigard MA; Gaucher P; Guéant JL
    Gastroenterol Clin Biol; 1994; 18(4):328-37. PubMed ID: 7958648
    [No Abstract]   [Full Text] [Related]  

  • 17. [News in digestive oncology].
    Michel P; Di Fiore F
    Bull Cancer; 2008 Jan; 95(1):117-20. PubMed ID: 18230577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SDI test using MTT for the evaluation of drug sensitivities of gastrointestinal cancer cells].
    Idota C; Yamauchi M; Takagi H
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):85-93. PubMed ID: 2324589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subrenal capsule assay using liver cancer specimens obtained by fine needle biopsy.
    Fukushima H
    Kurume Med J; 1991; 38(3):181-6. PubMed ID: 1664008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Targeted therapies in digestive oncology].
    Boutayeb S; Bensouda Y; Fadoulkhair Z; Bakkraoui K; Bachouchi M; Errihani H
    Pathol Biol (Paris); 2012 Aug; 60(4):264-8. PubMed ID: 22743093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.